Welcome to LookChem.com Sign In|Join Free

CAS

  • or

33184-59-7

Post Buying Request

33184-59-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33184-59-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 33184-59-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,1,8 and 4 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 33184-59:
(7*3)+(6*3)+(5*1)+(4*8)+(3*4)+(2*5)+(1*9)=107
107 % 10 = 7
So 33184-59-7 is a valid CAS Registry Number.

33184-59-7Relevant articles and documents

Metal-Free Arylation-Lactonization Sequence of γ-Alkenoic Acids Using Anilines as Aryl Radical Precursors

Felipe-Blanco, Diego,Gonzalez-Gomez, Jose C.

supporting information, p. 7735 - 7744 (2019/12/24)

The presence of salicylic acid (10 mol-%) and H2O (10 equiv.) significantly improves the arylation-lactonization sequence of γ-alkenoic acids with in situ formed diazonium salts (from bench stable anilines). The reaction is finished in less than 5 h without thermal or photochemical activation, giving access to a variety of γ,γ-disubstituted butyrolactones. The protocol is user-friendly and can be used at gram-scale or adapted to transform alkenols into phthalanes. Control experiments revealed that aryl radicals participate in the reaction and a plausible mechanism is proposed to include this and other mechanistic investigations, for the catalyzed and the background reaction.

Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1)

Asano, Yasutomi,Kitamura, Shuji,Ohra, Taiichi,Aso, Kazuyoshi,Igata, Hideki,Tamura, Tomoko,Kawamoto, Tomohiro,Tanaka, Toshimasa,Sogabe, Satoshi,Matsumoto, Shin-ichi,Yamaguchi, Masashi,Kimura, Hiroyuki,Itoh, Fumio

, p. 4715 - 4732 (2008/09/21)

A novel series of 4-phenylisoquinolones were synthesized and evaluated as c-Jun N-terminal kinase (JNK) inhibitors. Initial modification at the 2- and 3-positions of the isoquinolone ring of hit compound 4, identified from high-throughput screening, led to the lead compound 6b. The optimization was carried out using a JNK1-binding model of 6b and several compounds exhibited potent JNK inhibition. Among them, 11g significantly inhibited cardiac hypertrophy in rat pressure-overload models without affecting blood pressure and the concept of JNK inhibitors as novel therapeutic agents for heart failure was confirmed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33184-59-7